HOME
Leading the way to a cure

News & Events Overview

Stay Current! Bookmark this page to stay updated on current Lupus News and Events!


Lupus News

Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies

October 2, 2014
Eli Lilly and Company (NYSE: LLY) announced today it will discontinue development of tabalumab­ -- being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) --...

See full story >

 

NIH announces network to accelerate medicines for rheumatoid arthritis and lupus

September 24, 2014
The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP...

See full story >

 

Press Releases

Dr. Bruce Richardson Receives Lupus Insight Prize Recognizing Outstanding Contribution in Lupus Research

June 25, 2014
CHICAGO, IL -- Bruce Richardson, M.D., Ph.D., of the University of Michigan, was honored Wednesday as the second recipient of the Lupus Insight Prize, the award for use in innovative research on...

See full story >

 

Dr. Bruce Richardson Selected as the Second Recipient of the Lupus Insight Prize

June 9, 2014
CHICAGO, IL -– Bruce Richardson, M.D., Ph.D., of The University of Michigan, has been selected as the second recipient of the Lupus Insight Prize. The award provides $200,000 for use in innovative...

See full story >

 

Voices of Lupus

Dr. Levine - Diagonsing Lupus

ALR Grant Review Process

2013 Accomplishments



1.5 million

people in the U.S. have Lupus.

90 million

dollars committed to lupus research by the Alliance for Lupus Research.


We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.


Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.